Abstract
Constantly growing body of evidence suggests that hallmarks of oxidative stress are present in various central nervous system (CNS) disorders. Technological advantages in cell culturing made it possible to use neural cell / tissue cultures as experimental models for investigation of molecular mechanisms which underlie the development of oxidative stress condition, damage and adaptive responses to oxidative insults. This review is focused on the application of cell culture methodology for studies of oxidative stress condition in the brain. The review describes studies of biomarkers of oxidative stress-dependent cell damage and adaptive responses in various kinds of brain cell culture models. It discusses the use of cell / tissue culture models for elucidation of the role and pathogenesis of oxidative stress in neurodegenerative brain disorders, AIDS-associated brain pathology, drug abuse, and aging. The review underscores the importance of cell / tissue-based studies for testing of new antioxidants and development of therapeutic strategies for amelioration of oxidative damage in the CNS. The impact of new advances in gene and protein expression analysis on the cell / tissue culture-based research of oxidative stress in the CNS is also discussed.
Keywords: cell/tissue culture, in vitro, alzheimers disease, parkinsons disease, huntington disease, hiv-associated dementia, prion diseases, oxidative damage, brain
Current Neurovascular Research
Title: Cell Culture Models of Oxidative Stress and Injury in the Central Nervous System
Volume: 2 Issue: 1
Author(s): Marina V. Aksenova, Michael Y. Aksenov, Charles F. Mactutus and Rosemarie M. Booze
Affiliation:
Keywords: cell/tissue culture, in vitro, alzheimers disease, parkinsons disease, huntington disease, hiv-associated dementia, prion diseases, oxidative damage, brain
Abstract: Constantly growing body of evidence suggests that hallmarks of oxidative stress are present in various central nervous system (CNS) disorders. Technological advantages in cell culturing made it possible to use neural cell / tissue cultures as experimental models for investigation of molecular mechanisms which underlie the development of oxidative stress condition, damage and adaptive responses to oxidative insults. This review is focused on the application of cell culture methodology for studies of oxidative stress condition in the brain. The review describes studies of biomarkers of oxidative stress-dependent cell damage and adaptive responses in various kinds of brain cell culture models. It discusses the use of cell / tissue culture models for elucidation of the role and pathogenesis of oxidative stress in neurodegenerative brain disorders, AIDS-associated brain pathology, drug abuse, and aging. The review underscores the importance of cell / tissue-based studies for testing of new antioxidants and development of therapeutic strategies for amelioration of oxidative damage in the CNS. The impact of new advances in gene and protein expression analysis on the cell / tissue culture-based research of oxidative stress in the CNS is also discussed.
Export Options
About this article
Cite this article as:
Aksenova V. Marina, Aksenov Y. Michael, Mactutus F. Charles and Booze M. Rosemarie, Cell Culture Models of Oxidative Stress and Injury in the Central Nervous System, Current Neurovascular Research 2005; 2 (1) . https://dx.doi.org/10.2174/1567202052773463
DOI https://dx.doi.org/10.2174/1567202052773463 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
An Overview on Different Classes of Viral Entry and Respiratory Syncitial Virus (RSV) Fusion Inhibitors
Current Medicinal Chemistry Advancement in Polymer-based Carrier for DNA Vaccine
Current Pharmaceutical Design The Role of Iron Toxicity in Oxidative Stress-induced Cellular Degeneration in Down Syndrome: Protective Effects of Phenolic Antioxidants
Current Nutrition & Food Science Multivariate Statistical Tools for the Evaluation of Proteomic 2D-maps:Recent Achievements and Applications
Current Proteomics Cyclization in Opioid Peptides
Current Drug Targets Mitochondrial Drug Targets in Cell Death and Cancer
Current Pharmaceutical Design γ-AApeptides as a New Strategy for Therapeutic Development
Current Medicinal Chemistry Cholesterol Homeostasis Failure in the Brain: Implications for Synaptic Dysfunction and Cognitive Decline
Current Medicinal Chemistry MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance
Current Drug Targets Multifunctional Ligands with Glycogen Synthase Kinase 3 Inhibitory Activity as a New Direction in Drug Research for Alzheimer’s Disease
Current Medicinal Chemistry New Therapeutic Approaches by Using Microorganism-Derived Compounds
Current Medicinal Chemistry SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan
Current Neuropharmacology Prion Diseases: Time for a Therapy ?
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Protein Aggregation and Defective RNA Metabolism as Mechanisms for Motor Neuron Damage
CNS & Neurological Disorders - Drug Targets Will it Ever Become Possible to Prevent Dopaminergic Neuronal Degeneration?
CNS & Neurological Disorders - Drug Targets Resisting the Resistance in Cancer: Cheminformatics Studies on Short- Path Base Excision Repair Pathway Antagonists Using Supervised Learning Approaches
Combinatorial Chemistry & High Throughput Screening Silencing of Disease-related Genes by Small Interfering RNAs
Current Molecular Medicine Neuroprotective Strategies for the Treatment of Inherited Photoreceptor Degeneration
Current Molecular Medicine Design, Synthesis and Evaluation of Novel 2-piperidinyl Quinoline Chalcones/ Amines as Potential Antidepressant Agents
Letters in Drug Design & Discovery Sirtuins: Common Targets in Aging and in Neurodegeneration
Current Drug Targets